D-penicillamine, 900 mg daily, has been used in a randomized double-blind controlled trial to assess its use in the treatment of primary biliary cirrhosis. Nineteen patients received D-penicillamine and 13 placebo. The two groups were similar in age, duration of illness, liver function tests and liver histology. Before entry into the trial all but 2 of the patients had elevated liver copper concentrations measured on a biopsy sample by neutron activation analysis, and this copper accumulation may contribute to hepatocellular damage.
DISCUSSION
Dr H Berry (Lontdon): How did Dr Jain set about dosing his patients? Were they all given 900 mg initially, or were they given a 'go-low go-slow' regime, gradually increasing the dose? With the latter regime, it is possible that there might be fewer side-effects. Dr Jain: We started with 300 mg a day for one week, and 600 mg a day for the second week, rising to 900 mg in the third week.
Dr A G S Hill (Stoke Mandeville): Looking at the side-effects reported by other people so far at this meeting, I have been impressed by the high incidence of urticaria reported by Dr Jain. I think this may not be the general experience. Could this be connected in some way with liver dysfunction, perhaps an altered handling of something that produces urticaria ?
After three months in the trial patients taking D-penicillamine showed a significant (P<0.005) reduction in serum aspartate transaminase levels compared with the placebo group, and this reduction appears to be sustained. Serum bilirubin and alkaline phosphatase levels have not changed significantly. Ten patients have had a second liver biopsy after one year in the trial, and in the D-penicillamine-treated group the liver copper concentration has fallen by a significant degree (P<0.05) from 310 ,ug/g dry liver ± 128 to 84±36, compared with 512±200 to 404±139 in the placebo group (normal less than 60 ,g/g dry liver). Significant improvement in the histological features of cholestasis was seen in patients on the active drug, when assessed by the Fisher Exact Probability test, but the degree of inflammation and necrosis, and the histological stage of primary biliary cirrhosis remained similar in both groups. Six of the 19 patients on D-penicillamine had to discontinue the drug because of severe toxic effects, but despite this D-penicillamine is a promising treatment for patients with primary biliary cirrhosis.
[For full text, see Jain et al. 1977, Lancet i, 831.] Dr Jain: We do not think that penicillamine would be handled differently and accumulate because of cholestasis. Penicillamine does not seem to be metabolized in that way. I cannot explain the high incidence of urticaria on any other basis.
Dr D Felix-Davies (Birmingham): I believe that it was not Distamine that was used. Is it general experience that the incidence of urticaria and skin lesions is greater with other types of penicillamine?
Dr Jain: There are no hard data on the incidence of urticaria with the Bayer-Homburg type of penicillamine that we are using.
Dr Felix-Davies: Has Dr Lyle any information on this ?
Dr Lyle (Chairman): I do not think there is the slightest clinically significant difference between Dista and Homburg penicillamine. In general the same sort of adverse effects are seen in response to each and, as we have been told, these forms of penicillamine cannot be distinguished chemically or biologically once they have been dissolved.
Dr Felix-Davies: The human is a much more sensitive animal than other animals.
Dr Lyle: That is true, but the high incidence of urticaria in Dr Jain's patients I suspect has to do with these particular patients rather than with the penicillamine used.
Dr I Sternlieb (New York): Did any of these patients continue on cholestyramine and, if so, is anything known about the interaction of penicillamine and cholestyramine? Dr Jain: Yes, a number of these patients were on cholestyramine. We were careful to instruct them not to take the two drugs at the same time in case cholestyramine might inhibit the absorption of D-penicillamine. Also, a number of the patients on both drugs had side-effects such as taste loss, which proved that the drug was being absorbed. Dr Zilko: Is there any information about the changes in antimitochondrial antibodies in these patients ?
Dr Jain: This has been investigated, and there is no significant change in either group of patients. Dr J M Walshe (Cambridge): My experience, in looking after patients with Wilson's disease, is that more can be learnt about them by looking at them and talking to them than by any other means. How do these patients look? Do they honestly look better? Dr Jai: No, they honestly do not look better; they honestly feel quite bad on the penicillamine because of taste loss and other side-effects. I have to reassure them that it is worth while treating them for as long as they can tolerate the drug. Dr Lyle: Is it possible that a lower dose may be effective later on ?
Dr Jain: That is interestingwhat we hope to do is accumulate more data on the rate of decrease in liver copper concentration. If we can reduce it to normal levels after, say, one or two years, it might be reasonable to lower the dose.
Dr I H Scheinberg (New York): How many patients had taste loss and what was done about it?
Dr Jain: Three or four patients had taste loss. We did nothing about it because I do not think anything can be done. We did not want to give supplementary copper, and pyridoxine has not proved to be very effective.
Dr Scheinberg: Did it last long? Dr Jain: It has lasted for 10 months in one patient and she is very miserable with it. Dr Scheinberg: Could it be correlated with serum cmruloplasmin or copper levels?
Dr Jain: Serum copper levels have been measured. They are elevated in nearly all patients with primary biliary cirrhosis.
Dr Scheinberg: Were they measured in patients who had taste loss ? Dr Jain: We have not yet correlated that with taste loss. All I can say is that copper levels are elevated about 50% above normal in almost all the patients and that there were no outstandingly high levels. I would be surprised, therefore, if there were any correlationbut I can easily look at that.
